Data on the solid tumor cohort trial of CDX-1127 to be presented at the May 30 to June 3, 2014 ASCO meeting. Also CDX-001 ( Rindo ) accelerated approval study.
cldx will be in the mid $20's by ASCO- mark my words...
Sentiment: Strong Buy
you think mid $20s by ASCO ?
cdx 001 is the child study right?
Apparently Nick, its a Chines car door phone.
great time to buy many catalysts and ASCO big time.